Regulatory Science

Clene Inc. Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs

Clene Inc. Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs

Clene Inc. progresses in its regulatory strategy for CNM-Au8, with FDA meetings set to discuss ALS and MS treatments, marking a significant step towards potential accelerated approval.

June 30, 2025
InVitro International Reports Growth in Non-Animal Testing Technologies Amid Regulatory Shifts

InVitro International Reports Growth in Non-Animal Testing Technologies Amid Regulatory Shifts

InVitro International reports modest sales growth and highlights increasing global momentum toward non-animal testing methods in cosmetics and personal care industries, signaling potential regulatory changes.

May 13, 2025